| Application | Recommended Dilution |
|---|---|
| FC | 1:50-1:200 |
The production of the LRP2 recombinant monoclonal antibody involves a well-defined and rigorous process to ensure its quality and specificity. Initially, B cells are isolated from an immunized animal, with a synthesized peptide derived from human LRP2 used as the immunogen. Total RNA is extracted from the B cells, and cDNA is synthesized through reverse transcription. The LRP2 antibody genes are amplified using PCR with primers specific to the antibody constant regions and inserted into an expression vector. This vector is then introduced into host cells, enabling the production of the LRP2 recombinant monoclonal antibody. The antibody is harvested from the cell culture supernatant and subjected to affinity chromatography for purification, resulting in a highly purified preparation. Extensive characterization, including ELISA and FC analysis, is performed to validate the antibody's specificity and functionality, ensuring its ability to specifically recognize human LRP2 protein.
Email: support@cusabio.com
Distributors Worldwide